BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20800825)

  • 21. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells.
    Kitoh A; Ono M; Naoe Y; Ohkura N; Yamaguchi T; Yaguchi H; Kitabayashi I; Tsukada T; Nomura T; Miyachi Y; Taniuchi I; Sakaguchi S
    Immunity; 2009 Oct; 31(4):609-20. PubMed ID: 19800266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Foxp3-transduced polyclonal regulatory T cells suppress NK cell functions in a TGF-beta dependent manner.
    Zhou H; Chen L; You Y; Zou L; Zou P
    Autoimmunity; 2010 Jun; 43(4):299-307. PubMed ID: 20166879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CTLA-4 control over Foxp3+ regulatory T cell function.
    Wing K; Onishi Y; Prieto-Martin P; Yamaguchi T; Miyara M; Fehervari Z; Nomura T; Sakaguchi S
    Science; 2008 Oct; 322(5899):271-5. PubMed ID: 18845758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy.
    Sanvito L; Makowska A; Gregson N; Nemni R; Hughes RA
    Autoimmunity; 2009; 42(8):667-77. PubMed ID: 19886739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of regulatory T cells in systemic lupus erythematosus.
    Gerli R; Nocentini G; Alunno A; Bocci EB; Bianchini R; Bistoni O; Riccardi C
    Autoimmun Rev; 2009 Mar; 8(5):426-30. PubMed ID: 19185065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
    Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
    Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foxp3+CD4+ T cell-mediated immunosuppression involves extracellular nucleotide catabolism.
    Bynoe MS; Viret C
    Trends Immunol; 2008 Mar; 29(3):99-102. PubMed ID: 18258482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells.
    Boks MA; Zwaginga JJ; van Ham SM; ten Brinke A
    Scand J Immunol; 2010 Aug; 72(2):158-68. PubMed ID: 20618775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional regulation of Foxp3 in regulatory T cells.
    Haiqi H; Yong Z; Yi L
    Immunobiology; 2011 Jun; 216(6):678-85. PubMed ID: 21122941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells.
    Mor A; Keren G; Kloog Y; George J
    Eur J Immunol; 2008 Jun; 38(6):1493-502. PubMed ID: 18461565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
    Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
    J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection.
    Kapp JA; Honjo K; Kapp LM; Xu Xy; Cozier A; Bucy RP
    Int Immunol; 2006 Nov; 18(11):1549-62. PubMed ID: 16966495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid.
    Wang J; Huizinga TW; Toes RE
    J Immunol; 2009 Sep; 183(6):4119-26. PubMed ID: 19717521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1).
    Polanczyk MJ; Hopke C; Vandenbark AA; Offner H
    Int Immunol; 2007 Mar; 19(3):337-43. PubMed ID: 17267414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.
    Williams LM; Rudensky AY
    Nat Immunol; 2007 Mar; 8(3):277-84. PubMed ID: 17220892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G protein-coupled receptor 83 is dispensable for the development and function of regulatory T cells.
    Lu LF; Gavin MA; Rasmussen JP; Rudensky AY
    Mol Cell Biol; 2007 Dec; 27(23):8065-72. PubMed ID: 17893329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.